Coloplast A/S
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, wh… Read more
Coloplast A/S (CLPBF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.161x
Based on the latest financial reports, Coloplast A/S (CLPBF) has a cash flow conversion efficiency ratio of 0.161x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.23 Billion) by net assets ($13.80 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Coloplast A/S - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Coloplast A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Coloplast A/S Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Coloplast A/S ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
East West Bancorp Inc
NASDAQ:EWBC
|
0.026x |
|
Wal Mart de Mexico SAB de CV
PINK:WMMVF
|
0.100x |
|
GUOTAI JUNAN SEC. H YC1
F:153A
|
N/A |
|
CLP Holdings Ltd
PINK:CLPHY
|
0.069x |
|
Techtronic Industries Company Limited
PINK:TTNDF
|
0.112x |
|
Genuine Parts Co
NYSE:GPC
|
0.071x |
|
James Hardie Industries plc
PINK:JHIUF
|
0.031x |
|
IDEX Corporation
NYSE:IEX
|
0.052x |
Annual Cash Flow Conversion Efficiency for Coloplast A/S (2002–2025)
The table below shows the annual cash flow conversion efficiency of Coloplast A/S from 2002 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $16.09 Billion | $6.63 Billion | 0.412x | +167.35% |
| 2024-09-30 | $17.94 Billion | $2.77 Billion | 0.154x | -36.89% |
| 2023-09-30 | $17.30 Billion | $4.23 Billion | 0.244x | -60.27% |
| 2022-09-30 | $8.29 Billion | $5.10 Billion | 0.615x | -5.05% |
| 2021-09-30 | $8.17 Billion | $5.29 Billion | 0.648x | +0.79% |
| 2020-09-30 | $7.41 Billion | $4.76 Billion | 0.643x | +1.96% |
| 2019-09-30 | $6.91 Billion | $4.36 Billion | 0.630x | -7.25% |
| 2018-09-30 | $6.42 Billion | $4.36 Billion | 0.679x | +24.40% |
| 2017-09-30 | $5.95 Billion | $3.25 Billion | 0.546x | -8.58% |
| 2016-09-30 | $5.07 Billion | $3.03 Billion | 0.597x | -15.74% |
| 2015-09-30 | $4.71 Billion | $3.34 Billion | 0.709x | +41.48% |
| 2014-09-30 | $6.28 Billion | $3.15 Billion | 0.501x | +8.18% |
| 2013-09-30 | $6.77 Billion | $3.14 Billion | 0.463x | +5.67% |
| 2012-09-30 | $6.04 Billion | $2.65 Billion | 0.438x | -10.96% |
| 2011-09-30 | $4.48 Billion | $2.21 Billion | 0.492x | -3.91% |
| 2010-09-30 | $3.45 Billion | $1.77 Billion | 0.512x | -20.19% |
| 2009-09-30 | $2.85 Billion | $1.83 Billion | 0.642x | +11.11% |
| 2008-09-30 | $2.29 Billion | $1.32 Billion | 0.578x | +38.15% |
| 2007-09-30 | $2.40 Billion | $1.00 Billion | 0.418x | +21.47% |
| 2006-09-30 | $2.81 Billion | $966.00 Million | 0.344x | -36.01% |
| 2005-09-30 | $2.51 Billion | $1.35 Billion | 0.538x | +51.45% |
| 2004-09-30 | $2.37 Billion | $840.90 Million | 0.355x | -21.60% |
| 2003-09-30 | $2.01 Billion | $911.00 Million | 0.453x | -22.11% |
| 2002-09-30 | $1.57 Billion | $913.00 Million | 0.582x | -- |